Navigation Links
Soy compound may halt spread of prostate cancer
Date:3/13/2008

m of prostate cancer .The amount of genistein in the blood of the animals was comparable to human blood concentrations after consumption of soy foods, Bergan said.

The researchers found that while genistein didnt reduce the size of tumors that developed within the prostate, it stopped lung metastasis almost completely. They repeated the experiment and found the same result.

They then examined tissue in the animals, measuring the size of tumor cells nuclei to determine if the cells had flattened out in order to spread. Within a tumor, it is hard to tell where the borders of cells stop, so one way to measure adherence is to look at the size of the nuclei in cells and see if they are wider due to cell spread, Bergan said. And that is what we found, demonstrating that the drug is having a primary effect on metastasis.

He said that the study also found that mice fed genistein expressed higher levels of genes that are involved in cancer cell migration which, Bergan says, at first might not make sense in light of the studys conclusion that genistein almost completely blocked metastasis.

What we think is happening here is that the cells we put in the mice normally like to move. When genistein restricted their ability to do so, they tried to compensate by producing more protein involved in migration. But genistein prevented those proteins from being activated, he said. This is really a lesson for researchers who depend on biomarker studies to test whether a treatment is working. They need to be aware that those biomarkers might be telling only half of the story.

Bergan cautioned that much is unknown about use of genistein in preventing cancer spread. For example, it may be that the effects of the compound in people who have eaten soy all their lives is stronger than benefit seen in patients who have only started to use genistein.

The problem we have faced is that epidemiology studies that found men who eat soy are at re
'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Coloring Compound in Fruits, Veggies May Cut Colon Cancer Risk
2. Sugary Sodas High in Diabetes-Linked Compound
3. Red wine compound shown to prevent prostate cancer
4. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
5. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma
8. Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding
9. Cannabis Compound May Stop Metastatic Breast Cancer
10. Prostate Cancer Treatments Often Compound Existing Health Problems
11. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ubstantially higher rates of mental health problem...s from a systematic review and meta-analysis publi...or studies over the past four decades containing d...ess people, Seena Fazel and colleagues of the Univ...,684 homeless individuals based in the US, UK, mai...
(Date:12/2/2008)...mposium today hosted by Johns,Hopkins University...s presented,the latest research in brain plastici... into technology to improve lives. Henry Mahncke, ...e that cognitive intervention developed by,Posit ...s ability to,reorganize itself throughout life. ...
(Date:12/2/2008)... assault are unsettling; the Department of Justice...e victim of attempted or actual sexual assault dur...rs from two universities, including the University...are unaware of drug-facilitated sexual assault and...including leaving drinks unattended. , "These f...
(Date:12/2/2008)...rprise software and online services veteran is exp...ers of Yugma,s instant web conferencing solutions ... December 2, 2008 -- Yugma , the leading web conf...aborate instantly using the Internet, announced th... Officer. , , ,Vas has more than 20 years of exper...
Breaking Medicine News(10 mins):Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3
... dengue cases in the national capital civic author...k the menace//, including prosecuting people who c...v, deputy municipal health officer of Delhi said, ...ted of which six proved to be fatal. We have recei...
...ealthcare treatment meted to those suffering menta...udy has found.// An investigation of 8 million hea...s opened a can of worms. The study spanning 18 m... a propensity suffer other illness alongside, as c...
...re is a “crisis” over lack of donors at sperm bank...linics being totally out of stock//, women and cou...problem. In 1990s, the highest number of donors w...decreasing. To make it worse, last year a new law ...
... reduce the bio-terrorism threat of the Venezuelan...hers at the University of Texas Medical Branch at ...al step in the development of effective drug thera...litis (VEE) virus, which is a potential bio-terror...
Other Medicine News:Health News:Shortage of donors at sperm bank clinics 2Health News:A New drug Developed To Fight The Bio-Terrorism Threat Of VEE Virus 2
(Date:12/1/2008)...PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc...ncet , one of the world,s leading medical journals...n regulator, experimental compound tasimelteon (VE... entitled "Melatonin agonist tasimelteon (VEC-162)...o randomised controlled multicentre trials." Resul...
(Date:12/1/2008)...hatasia Treated With ENB-0040 at Children,s Hospit...MONTREAL, Dec. 1 Enobia Pharma, an...loping novel therapeutics for serious bone disorde...in its clinical program for hypophosphatasia was d...herapy (ERT) with ENB-0040 for the treatment of th...
(Date:12/1/2008)...December 1 Following a,...t to procure an MVA-based,third generation small...,Canada, on behalf of the Canadian Department of N...an Nordic for the delivery of IMVAMUNE(R). , ...R) as part of the,country,s bio-preparedness prog...
(Date:11/30/2008).... 1 Older adults who ex...w and a greater number of small blood vessels in t... the annual meeting of the Radiological Society of...ucted at the University of North Carolina ( UNC)...ns of older adults who exercise to brain scans of ...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Thyroid Hormone Could One Day Treat Osteoporosis 13954 1Thyroid Hormone Could One Day Treat Osteoporosis 13954 2Thyroid Hormone Could One Day Treat Osteoporosis 13954 3Alarming growth in expected CO2 emissions in China finds UC analysis 2451 1Alarming growth in expected CO2 emissions in China finds UC analysis 2451 2Alarming growth in expected CO2 emissions in China finds UC analysis 2451 3GFX 3A Wrinkle Killer or Botox 28R 29 Hit Man 3F 13950 1GFX 3A Wrinkle Killer or Botox 28R 29 Hit Man 3F 13950 2GFX 3A Wrinkle Killer or Botox 28R 29 Hit Man 3F 13950 3Injection of human umbilical cord blood helps the aging brain 13948 1Injection of human umbilical cord blood helps the aging brain 13948 2
...ay 29, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) ...007) study of aztreonam lysine for inhalation for,...who have,pulmonary Pseudomonas aeruginosa (P. aeru...e at Day 28 from baseline in respiratory,symptoms,...Revised,(CFQ-R), a patient-reported outcome (PRO) ...
...for Organ Transplantation, HORSHOLM, Denmark, May ...a announces positive Phase I clinical results for,... Heads into US,Phase II clinical trials for organ ...:LCP) announces positive results,from its Phase I ..., once-daily tacrolimus tablet. , A series of Phas...
Other Medicine Technology:Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 2Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 3Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 4Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 5LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3
VERSASTEP™ Reposable Short Single-Use For use with VERSASTEP™ Short Reusable Cannula, Dilator.
VersaStep™ Reposable Sterilization Trays.
VERSASTEP™ Plus Long Instrument for applications in laparoscopic procedures., ,The VERSASTEP™ Plus Long Instrument with 150mm Working Length is a unique endoscopic entry device that has
...ade; Blunt Tip Trocar consists of a blunt obturato... , ,The valve body assembly contains an internal ... instruments are inserted or withdrawn. The Autosu...verters to allow insertion of instruments of diffe...
Medicine Products: